These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 13832156)

  • 21. DRUG-INDUCED CHANGES OF THE METABOLISM OF 5-HYDROXYTRYPTAMINE IN THE BRAIN OF X-RAY-TREATED RATS.
    PALAIC D; SUPEK Z
    J Neurochem; 1965 Apr; 12():329-33. PubMed ID: 14336232
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog.
    STONE CA; ROSS CA; WENGER HC; LUDDEN CT; BLESSING JA; TOTARO JA; PORTER CC
    J Pharmacol Exp Ther; 1962 Apr; 136():80-8. PubMed ID: 13917453
    [No Abstract]   [Full Text] [Related]  

  • 23. Inactivation of 3-(3,4-dihydroxyphenyl)alanine decarboxylase by 2-(fluoromethyl)-3-(3,4-dihydroxyphenyl)alanine.
    Maycock AL; Aster SD; Patchett AA
    Biochemistry; 1980 Feb; 19(4):709-18. PubMed ID: 7356954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [COMPARATIVE ACTION OF 2 DECARBOXYLASE INHIBITORS ON THE METABOLISM OF ENDOGENOUS AND EXOGENOUS 5-HYDROXYTRYPTAMINE].
    KUNZ E
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():1-8. PubMed ID: 14116929
    [No Abstract]   [Full Text] [Related]  

  • 25. Brain 5-hydroxytryptamine, 5-hydroxytryptophan decarboxylase, and monoamine oxidase of normal, thyroid-fed, and propylthiouracil-fed male and female rats.
    SKILLEN RG; THIENES CH; STRAIN L
    Endocrinology; 1961 Dec; 69():1099-102. PubMed ID: 13913630
    [No Abstract]   [Full Text] [Related]  

  • 26. The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain.
    BOGDANSKI DF; WEISSBACH H; UDENFRIEND S
    J Neurochem; 1957; 1(3):272-8. PubMed ID: 13429371
    [No Abstract]   [Full Text] [Related]  

  • 27. alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase.
    Palfreyman MG; Danzin C; Bey P; Jung MJ; Ribereau-Gayon G; Aubry M; Vevert JP; Sjoerdsma A
    J Neurochem; 1978 Oct; 31(4):927-32. PubMed ID: 308998
    [No Abstract]   [Full Text] [Related]  

  • 28. Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan.
    SJOERDSMA A; OATES JA; ZALTZMAN P; UDENFRIEND S
    N Engl J Med; 1960 Sep; 263():585-8. PubMed ID: 13831424
    [No Abstract]   [Full Text] [Related]  

  • 29. SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.
    DAY MD; RAND MJ
    Br J Pharmacol Chemother; 1964 Feb; 22(1):72-86. PubMed ID: 14126060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [ACTION OF CERTAIN L-DOPA/5-HTP DECARBOXYLASE INHIBITORS ON HYPOTHALAMO-HYPOPHYIAL NEUROSECRETION IN THE RAT].
    SOULAIRAC A; SOULAIRAC ML
    C R Seances Soc Biol Fil; 1964; 158():1445-7. PubMed ID: 14250544
    [No Abstract]   [Full Text] [Related]  

  • 31. EFFECT OF MONOAMINE RELEASERS AND DECARBOXYLASE INHIBITORS ON ENDOGENOUS 5-HYDROXYINDOLE DERIVATIVES IN BRAIN.
    PLETSCHER A; BURKARD WP; GEY KF
    Biochem Pharmacol; 1964 Mar; 13():385-90. PubMed ID: 14157599
    [No Abstract]   [Full Text] [Related]  

  • 32. Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label.
    Bertoldi M; Dominici P; Moore PS; Maras B; Voltattorni CB
    Biochemistry; 1998 May; 37(18):6552-61. PubMed ID: 9572873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of D,L-alpha-monofluoromethyldopa to distinguish subcellular pools of aromatic amino acid decarboxylase in mouse brain.
    Gardner CR; Richards MH
    Brain Res; 1981 Jul; 216(2):291-8. PubMed ID: 6166354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation.
    Soares-da-Silva P; Pinto-do-O PC
    Br J Pharmacol; 1996 Mar; 117(6):1187-92. PubMed ID: 8882614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHARACTERISTICS OF THE INHIBITION OF AROMATIC L-AMINO ACID DECARBOXYLASE BY ALPHA-METHYLAMINO ACIDS.
    LOVENBERG W; BARCHAS J; WEISSBACH H; UDENFRIEND S
    Arch Biochem Biophys; 1963 Oct; 103():9-14. PubMed ID: 14065980
    [No Abstract]   [Full Text] [Related]  

  • 36. [EFFECTS OF RESERPINE, ALPHA-METHYL-DOPA AND THEIR INTERACTIONS ON MORPHINE ANALGESIA].
    TSOU K; TU ZH
    Sheng Li Xue Bao; 1963 Dec; 26():360-6. PubMed ID: 14097224
    [No Abstract]   [Full Text] [Related]  

  • 37. INHIBITION OF CEREBRAL DECARBOXYLASE AND BEHAVIOUR.
    PLETSCHER A; PRADAM DA; STEINER FA
    Int J Neuropharmacol; 1964 Dec; 3():550-64. PubMed ID: 14344493
    [No Abstract]   [Full Text] [Related]  

  • 38. ACTION OF ALPHA-METHYLDOPA ON THE PHARMACOLOGICAL AND BIOCHEMICAL EFFECT OF RESERPINE IN RATS AND MICE.
    PFEIFER AK; GALAMBOS E
    Biochem Pharmacol; 1965 Jan; 14():37-40. PubMed ID: 14286100
    [No Abstract]   [Full Text] [Related]  

  • 39. 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN RAT BRAIN: EFFECT OF HYPOTHALAMIC LESIONS.
    HELLER A; SEIDEN LS; PORCHER W; MOORE RY
    Science; 1965 Feb; 147(3660):887-8. PubMed ID: 14245772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism between L-alpha-methyl DOPA and reserpine.
    NECINA J
    Life Sci (1962); 1962 Jul; 1():301-3. PubMed ID: 14478718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.